Healthcare

The rapidly advancing diagnostics space has resulted in development of various companies involved in production of diagnostic equipment as well as distribution of testing apparatus and assemblies. The histopathology testing equipment market is no exception, wherein top five companies involved in the development of histopathology testing equipment account for a significant share of the overall market revenue. Top companies such as Thermo Fisher Scientific, Hoffman-la-Roche Ltd., Leica Biosystems, Agilent Technologies Inc., and Merck KGaA collectively account for a revenue share of over 62% in the histopathology testing equipment market.

Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=2240

Increasing awareness regarding cancer screening coupled with higher demand for advanced histopathology testing equipment from diagnostic centers are expected to provide potential avenues of growth for tier 1 manufacturers. These companies are more focused on new product launches, expansion of their current product lines.

Fact.MR has recently published a fresh research report that carefully inspects the ENT surgical devices market for the period between 2018 and 2028. The study titled “ENT Surgical Devices Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028”, serves as an informative data source that includes knowledge associated to market dynamics, market value (US$ Mn), Y-o-Y growth comparison and a lot more. Overall, the concerned assessment unravels the actual scenario prevailing in the global ENT surgical devices market influenced by technological innovations and medical trends.

According to research findings, the global market for ENT surgical devices is likely to surpass US$ 2,500 million in 2019. Furthermore, the ENT surgical devices market is projected to grow at 6.4% CAGR by the end of 2028. This outstanding growth can be credited to certain motivating aspects such as technological advancements augmenting ENT procedure outcome and reimbursement policies favoring ENT surgeries.

Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=2454

Ongoing Implementation of Advanced Technology Supporting Market Growth

ENT diagnostic devices market is estimated to hit US$ 2.3 billion in 2019, according to a new study by Fact.MR. The market grew at 6.3% y-o-y in 2018 with bronchoscopes accounting for nearly one third of the global revenues. Overall growth of the ENT diagnostic devices market can be attributed to,

• Advanced technology incorporations in ENT diagnostic devices
• Favorable reimbursement policies for ENT procedures
• Development of efficient and low-priced devices

Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=2468

According to Fact.MR study, the ENT endoscopes are estimated to account for over half the revenues of the ENT diagnostic devices market in 2019. Endoscopy has played a significant role in the diagnosis of ear, nose and throat related diseases as well as successful treatment outcomes. Owing to this, ENT endoscopes have become the most common devices in the ENT clinics.

The relatively new technology for integrating magnetic resonance imaging (MRI) with radiation therapy is becoming increasingly prevalent, with revenues from the MRI-guided radiation therapy systems market exceeding US$ 220 Mn in 2018, according to a recent study by Fact.MR.  This remarkable growth potential of the MRI-guided radiation therapy systems market can be attributed to burgeoning adoption of innovative technologies in the cancer diagnosis & treatment, alongside growing focus on patient-centric care.

Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=2572

The study assesses macro and microeconomic factors that define the growth prospects of the MRI-guided radiation therapy systems market. It finds that leading players in the rapidly-growing healthcare sector are vying for new techniques in cancer treatment to compensate for involuntary patient movements and improve precision to a much higher degree. In addition, the paradigm shift in preference of cancer patients towards radiation therapies, from invasive to non-invasive procedures, is expected to remain instrumental in adoption of MRI-guided radiation therapy systems in cancer care.

Worldwide sales of rapid oral fluid screening devices are estimated to surpass 17,700 thousand units in 2019, up from nearly 16,500 units in 2018. The growing demand for of rapid oral fluid screening devices can be attributed to the ever-augmenting cases of drug abuse and alcoholism in many countries across the globe. Tougher regulations and mandates for drug and alcohol testing continue to induce momentum in this market.

Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=2694

The study finds that efficacy of oral fluid for drug testing is being widely acknowledged on account of accuracy and precision of results. Multiple applications, such as pain management, drug treatment, and DUID (driving under influence of drugs) or drug-impaired driving, entail use of rapid oral fluid screening devices for instant yet accurate results. In addition, increasing number of hospital-based laboratories and independent laboratories are making use of rapid oral fluid screening devices to perform multimodal tests.

The US$ 1.78 billion actigraphy sensor and PSG devices market on course to grow at 4.3% in 2019, according to Fact.MR’s latest analysis. According to the study, actigraphy sensor and PSG devices market remains a highly consolidated landscape, with Tier I companies maintaining their hegemony despite the foray of new entrants.

Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=2829

According to the study, as a result of the convergence of healthcare and technology, new medical technology (MedTech) products are gaining ground. Growing consumer awareness about—and inclination towards—technologically advanced actigraphy sensor and PSG devices has attracted both, tech industry leaders and startups, to enter the healthcare industry with more innovative actigraphy sensor and PSG devices.

The Fact.MR study provides comprehensive assessment of the future growth prospects of the actigraphy sensor and PSG devices market to predict that the market will grow at an incremental 4.6% value CAGE through 2026.

According to a recent research by Fact.MR, the citicoline market is estimated to surpass US$ 550 million in 2019. Citicoline demand is driven by a range of factors, notably increasing geriatric population and growing use among eSports players. The study offers in-depth and incisive insights on key factors influencing the global demand for citicoline.

Supplement Consumption Among eSports Players: A Lucrative Opportunity

Growing popularity and increasing investments in eSports is helping the market go mainstream which, in turn, is opening an assortment of opportunities for various industries. Players participating in eSports tournaments are seeking cognitive enhancing supplements which can help them concentrate, plot strategies, and improve working memory. Additionally, a ban on the use of other nootropics such as Ritalin and Adderall in eSports leagues is creating demand for ‘permissible’ supplements. Citicoline’s negligible toxicity and its organic nature is making it an appealing prospect for eSports players. With regulations allowing the use of citicoline in functional food and supplements, manufacturers are increasingly focusing towards including the compound in their products to capitalize on the bolstering demand for cognitive-enhancing supplements in eSports.

According to a recently released Fact.MR study, revenues from dyslipidemia therapeutics market surpassed US$ 36 billion in 2018. Low-density lipoproteins held approximately two-thirds of revenues from dyslipidemia therapeutics worldwide in 2018. As high LDL levels have been associated with increased risks of heart attacks, strokes, and other cardiovascular problems in humans, governments around the world are launching various campaigns to raise awareness about the adverse impact of high LDL levels in the blood.

Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=2928

The growing prevalence of cardiovascular disorders worldwide has prompted individuals to effectively manage their LDL levels. To capitalize on the current trends prevalent in the dyslipidemia therapeutics market, pharmaceutical companies continue to strive towards developing new and improved therapies to lower LDL levels, and effectively manage the percentage of other lipids in the blood. A range of new treatments such as combination therapies, gene editing, and novel target drugs are under development, particularly for dyslipidemia therapeutics.

According to a recent study of Fact.MR, the natural cold, cough, and sore throat remedies market is expected to surpass revenues worth US$ 4,800 Mn in 2019. The rising popularity of alternative medicine and therapies, coupled with the widespread adoption of natural medication in healthcare worldwide are key factors that are fueling growth of the natural cold, cough, and sore throat remedies market.

The study opines that natural syrups and drops will continue to hold nearly half share of the market, accounting for revenues worth over US$ 2,200 Mn in 2018. The palatable taste of syrups and the presence of multiple ingredients deemed to boost the overall immunity, while combating cold and cough, are pivotal reasons behind increased traction for natural syrups & drops. For instance, sales of Nin Jiom Pei Pa Koa, a Chinese herbal syrup for treating cough, witnessed a significant surge in sales in the US during the flu season in 2018, not only because it was effective but also because consumers found the syrup’s taste surprisingly pleasant.

Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=2988

According to a recent Fact.MR study, the genealogy products and services market is likely to be valued at over US$ 3 billion in 2019. The market is likely to continue its bullish run with a myriad of factors influencing the strategy of key players. Surging demand for genetic and DNA testing in an assortment of industries, coupled with the growing awareness about genealogy are some of the vital factors bolstering market growth. Technological advancement also remains a key influencer, as efficient data storage and retrieval become key priorities for market players.

Demand for genealogy in tracing lineage and creating family trees is on the rise with service providers using aggressive marketing techniques to draw in new consumers. Commercials promoting self-discovery through lineage tracing are increasingly finding greater appeal as they resonate with the human psychology of tracing their heritage in order to gain a sense of wider connection.

Additionally, the concept is being popularized by an array of television programs such as “Who Do You Think You Are?” and features providing information about the ancestry of famous personalities and linking it to their career and life.